By Jennifer Rigby LONDON (Reuters) – Every country in the world will see rates of diabetes rise in the next 30 years without action, according to a new global study. There are currently 529 million people in the world with diabetes, the study led by researchers at the Institute of Health Metrics and Evaluation at…
By David Shepardson WASHINGTON (Reuters) – A U.S. appeals court panel Thursday vacated an April 2022 ruling that had declared unlawful a government order requiring masks on airplanes and other transportation modes during the COVID-19 pandemic. The Justice Department had asked 11th Circuit Court of Appeals to declare the issue moot after President Joe Biden…
By Leroy Leo and Aditya Samal (Reuters) – The U.S. health regulator has granted accelerated approval to Sarepta Therapeutics’ first-of-its-kind gene therapy for Duchenne muscular dystrophy (DMD), an inherited progressive muscle-wasting disorder that almost always affects young boys. Sarepta said on Thursday the Food and Drug Administration had approved the treatment for children aged between…
By Daniel Trotta (Reuters) – A U.S. judge on Wednesday struck down a Florida rule and a statute that banned state Medicaid payments for transgender healthcare, marking the second defeat in two weeks for anti-transgender legislation in the state. U.S. District Judge Robert Hinkle declared the state’s practices invalid, saying they violated the constitutional right…
By Nikolaj Skydsgaard COPENHAGEN (Reuters) -A thyroid cancer safety signal was raised by the EU’s drugs watchdog last month over several Novo Nordisk products including semaglutide, which is used in popular diabetes and obesity medicines Ozempic and Wegovy. The European Medicines Agency (EMA) raised the safety signal, which is a way to monitor potential adverse…
LONDON (Reuters) – Two creditors of France’s Orpea have filed an application in a U.S. court against another creditor and the creditor’s financial adviser to obtain and use documentation related to the care home operator’s French legal proceedings, a source close to the situation said. Orpea creditors Kyma Capital and LMR Partners lodged on Tuesday…
VATICAN CITY (Reuters) – Pope Francis skipped reading a planned speech at a conference on Thursday, saying he still had breathing problems following a hernia operation this month. “I am still under the effects of anaesthesia, my breathing is not good,” Francis told a meeting of the Catholic Oriental Church, saying delegates would instead receive…
(Reuters) -Transamerica owner Aegon on Thursday forecast a higher free cash flow and dividend in 2025, flagging untapped potential in the U.S and stepping up its strategy to invest in higher-return assets. The Dutch-listed insurer said it sees free cash flow of about 800 million euros ($878.96 million) in 2025, up from the 600 million…
(Reuters) – Telix Pharmaceuticals rose over 3% on Thursday to hit an all-time high, after the radiopharma company said it would acquire UK-based medical device firm Lightpoint Medical. Telix had entered an agreement to buy Lightpoint and its radio-guided surgery business SENSEI, which specialises in intra-operative detection of cancer in real time, the company said…
By Michael Erman and Raghav Mahobe (Reuters) -A panel of advisers to the U.S. Centers for Disease Control and Prevention (CDC) on Wednesday recommended that new vaccines from Pfizer and GSK to prevent severe respiratory syncytial virus (RSV) infections be available to older adults in the U.S. but stopped short of saying all of them…
